Program Type
Disease
Project Status

Displaying 51 - 75 of 94

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML)
The Problem Detection of measurable residual disease (MRD) is a strong predictor of relapse in acute and chronic leukemia, but its integrat...
Biomarkers Consortium – Neurofilament as a Blood-Based Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (FTD)
The Problem The earliest stages of FTD are hard to detect until the disease has progressed and damage is more permanent. Experts believe th...
Biomarkers Consortium – Treatments Against RA and Effect on FDG PET-CT (TARGET Biomarker Study)
The Problem Rheumatoid arthritis (RA) is currently difficult to treat and people with RA are at increased risk for developing cardiovascula...
Cancer Research Fund
The Cancer Research Fund enables individuals to support cancer research at the National Cancer Institute (NCI). Goals Enable individua...
CarMollNat Muscular Dystrophy Fund
"In memorium for my parents, Molly Harris and Nathan Harris, and my brother, Merton Harris- They were so much to so many.” - Carol-Ann Ha...
Clinical Center Drug Donations
Overview The Clinical Center In-Kind Drug Donation Program provides pharmaceuticals that are donated through the public-private partnership...
Combining Epitope-Based Vaccine Design with Informatics-Based Evaluation to Obtain a Universal Influenza Vaccine
The Problem Every year, an estimated 291,000 to 646,000 people worldwide die from seasonal influenza-related respiratory illnesses. Current...
Biomarkers Consortium – Vol-PACT Phase II: Advanced metrics and modeling with Volumetric CT for Precision Analysis of Clinical Trial results
The Problem The cancer research field lacks well-tested biomarkers to measure disease progression and to predict how patients respond to tr...
Remote Digital Monitoring and Patient-Centric Medical Product Development
Join us on June 24th and 25th for a collaborative workshop that brings together industry leaders, regulatory bodies, researchers, and patien...
Biomarkers Consortium – Inflammatory Markers for Early Detection and Subtyping of Neurodegenerative and Mood Disorders
The Problem Neurodegenerative and psychiatric conditions such as Alzheimer’s disease and Major Depressive Disorder present very differentl...
Biomarkers Consortium – Mucosal Healing in UC: Definition, Treatment Target and Clinical Endpoints
The Problem Mucosal healing is an important outcome in clinical trials of drugs to treat ulcerative colitis, yet Researchers lack a standar...
Biomarkers Consortium – NiP-Metastatic Prostate Cancer
Overview Metastatic castration-resistant prostate cancer (mCRPC) is the second leading cause of cancer death of American men. Over 80% of t...
Biomarkers Consortium – Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer’s Disease
The Problem Early treatment of Alzheimer’s disease requires early diagnosis. Yet available methods to diagnose early AD are expensive or ...
Biomarkers Consortium – PROGRESS OA: Clinical Evaluation and Qualification of Osteoarthritis Biomarkers
Overview The Biomarkers Consortium’s PROGRESS OA - Clinical Evaluation and Qualification of Osteoarthritis Biomarkers Project is the seco...
Biomarkers Consortium – The Performance of Novel Cardiac Biomarkers in the General U.S. Population
The Problem Cardiovascular disease is one of the most lethal conditions in the United States, yet Researchers lack the tools needed to asse...
Biomarkers Consortium – Clinical Evaluation and Qualification of Translational Kidney Safety Biomarkers
The Problem When conducting clinical trials of any drugs that could cause acute kidney injury, Researchers need biomarkers that can detect ...
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
The Problem Individuals with Alzheimer’s disease often do not show symptoms during the early stages of disease, limiting clinicians’ ab...
African Centers of Excellence in Bioinformatics
The African Centers of Excellence in Bioinformatics is a strategic public-private partnership of the National Institute of Allergy and Infec...
Age-Related Eye Disease Study 2 (AREDS2) Ancillary Study
Overview The project was completed in 2013. The Age-Related Eye Disease Study 2 (AREDS2) overseen by the National Eye Institute (NEI) examin...
Amgen Scholars Program at NIH
Amgen Scholars Program at NIH" In 2015, the NIH became one of 24 leading institutions taking part in the Amgen Scholars Prog...
Biomarkers Consortium – Bone Quality Project
The Problem Patients with osteoporosis, other bone diseases or increased risk for bone fractures have diminished bone strength and quality,...
Adam J. Berry Memorial Fund
Overview Since 2003, the Adam J. Berry Memorial Fund has supported travel  for early-career Australian scientists to work at the NIH, in p...
ACTIV Seminar Series: Post-Acute Sequelae of SARS-CoV-2
Overview COVID patients who experience lingering symptoms for months or weeks after initial recovery are said to have post-acute sequelae o...
Accelerating Medicines Partnership® Program – Rheumatoid Arthritis, Systemic Lupus Erythematosus
The Problem Autoimmune disorders such as Rheumatoid Arthritis and Systemic Lupus Erythematosus are biologically complex; understanding the ...

Diseases

Partner With Us